ZHANG Lanfang, WANG Zhanqi, LI Xiaohong, WANG Yanfei, ZHAO Shujun, HAN Kunpeng. Influence of rosuvastatin intensive therapy on serum concentration of MMP-9 and APN in acute myocardial infarction patients without percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2014, (1): 12-15. DOI: 10.7619/jcmp.201401004
Citation: ZHANG Lanfang, WANG Zhanqi, LI Xiaohong, WANG Yanfei, ZHAO Shujun, HAN Kunpeng. Influence of rosuvastatin intensive therapy on serum concentration of MMP-9 and APN in acute myocardial infarction patients without percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2014, (1): 12-15. DOI: 10.7619/jcmp.201401004

Influence of rosuvastatin intensive therapy on serum concentration of MMP-9 and APN in acute myocardial infarction patients without percutaneous coronary intervention

More Information
  • Published Date: July 09, 2014
  • 张晓丽, 吴强, 彭林林. 心肌梗后心脏胶原重塑与心功能的变化 [J]. 贵州医学, 2008(6):487.
    Serruys P W, Feyter P, Macaya C. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention:a randomized controlled trial [J]. NATURE, 2000.233.
    王小斌, 朱莉, 殷屹岗. 急性心肌梗死患者经桡动脉途径行急诊PCI疗效观察 [J]. 实用临床医药杂志, 2010(7):47.
    孙党红, 王月, 张华. 循证护理在心脏介入治疗术后预防并发症中的应用 [J]. 实用临床医药杂志, 2010, (20):51.
    叶桂萍. 整体护理干预对老年冠心病心脏介入治疗的影响 [J]. 实用临床医药杂志, 2010, (16):41.
    松涛, 李凌, 高传玉. 末端B型利钠肽原对经皮冠状动脉介入治疗后急性心肌梗死患者预后预测价值 [J]. 南方医科大学学报, 2010(3):642.
    黄炫生, 张励庭, 袁勇. 急性心肌梗死急诊介入治疗疗效与血管再通时间的关系 [J]. 南方医科大学学报, 2007(1):119.
    邱曼, 孙乐标. 急性心肌梗死患者生化指标的变化与心肌梗死范围的研究 [J]. 重庆医学, 2012, (26):264.
    张晓云, 魏芳倩, 徐力. APN MMP-9 hs-CRP在冠心病老年患者中的表达及临床意义 [J]. 内蒙古医学杂志, 2011(5):513.
    樊国亮, 修宗谊, 谷天祥. EPO对糖尿病兔心肌梗后心肌重塑基质金属蛋白酶表达的影响 [J]. 中国医科大学学报, 2012(1):56.
    张婷. 盐酸吡格列酮对2型糖尿病患者血管内皮功能和高敏C反应蛋白的影响 [J]. 实用临床医药杂志, 2011, (13):29.
    朱启伟, 王浩, 张今尧. 吡格列酮对缺氧复氧心肌细胞损伤的保护作用及对蛋白激酶C表达的影响 [J]. 南方医科大学学报, 2011, (11):1819.
    谭国据, 陈俏容, 林秋果. 门冬胰岛素联合吡格列酮治疗肝源性糖尿病的临床观察 [J]. 海南医学院学报, 2011(8):1057.
    田亚强, 苏旭东, 赵家军. 吡格列酮对高脂饮食SD大鼠心功能的影响 [J]. 第三军医大学学报, 2011(1):65.
    宋少鹏. 瑞舒伐他汀对不稳定型心绞痛患者血清细胞因子和心肌缺血的影响 [J]. 中山大学学报, 2009(5):189.
    郝晓燕, 田建会, 赵晖. 瑞舒伐他汀对于稳定型心绞痛PCI术病人炎症因子的影响 [J]. 青岛大学医学院学报, 2010(4):312.
    梁文生, 蒋卫红. 急性冠脉综合征患者血清脂联素与C反应蛋白关系的研究 [J]. 临床内科杂志, 2008, (10):676.
    Pischon T, Girman C, Hotsmidligil G S. Plasma adiponectin level and risk of myocardial infarction in men [J]. JAMA:the Journal of the American Medical Association, 2004, (14):1730.
    Xue M, Yong V W. Mtrix metalloproteinases in intracerebral hemorrchage [J]. Neurological Research, 2008(8):775.
    郭完计, 李晶, 秦中胜. 不稳定型心绞痛患者AngⅡ、hs-CRP及MMP-9相关性初探 [J]. 中华全科医学, 2012(2):179.
    Fiotti N, Altamura N, Orlandoc. Metalloprioteinases-2, -9andTIMP-1expression in stable and anstable coronary plaques undergoing PCI [J]. International Journal of Cardiology, 2008(3):350.
    刘军锋, 贾克刚, 刘运德. 基质金属蛋白酶与心脏重构及心肌病理损害的研究进展 [J]. 中华老年心脑血管病杂志, 2007(7):499.
    GUO H, SHI Y, LIU L. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice [J]. ARCHIVES OF MEDICAL RESEARCH, 2009(5):345.
    邹勇, 杨天伦, 蒲晓群. 瑞舒伐他汀对PCI患者术后脂联素和高敏C反应蛋白的影响 [J]. 中国医药导报, 2012(5):69.
    李杰, 李光勤, 蒋国会. rt-PA及尿激酶溶栓后对MMP-9及脑出血性转化的对比研究 [J]. 重庆医科大学学报, 2009(8):1000.
  • Related Articles

    [1]WANG Jie, SHI Dongmei. Nursing management for percutaneous coronary intervention in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(19): 78-82. DOI: 10.7619/jcmp.20211579
    [2]YUAN Shanqi, ZHAO Hongmin, WANG Xiaoye, ZHANG Xi′an, HOU Pengfei, LIU Zhanhui. Application analysis of carotid ultrasound combined with detections of vascular endothelial growth factor, matrix metalloproteinase-9 and hypersensitive C-reactive protein in the stability of atherosclerotic plaque[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 27-29, 33. DOI: 10.7619/jcmp.201917008
    [3]ZHANG Yan, TU Jing, HUANG Hui. Study on the correlation between serum adiponectin and placental matrix metalloproteinase 9 in patients with gestational hypertension[J]. Journal of Clinical Medicine in Practice, 2017, (3): 96-98. DOI: 10.7619/jcmp.201703029
    [4]SHEN Dongjie, LIU Tao, ZHAO Enhao, YUAN Jianming. Effect of S-1 combined with oxaliplatin on treatment of advanced gastric cancer and its influence on expressions of MMP-9 and VEGF[J]. Journal of Clinical Medicine in Practice, 2015, (5): 41-43,47. DOI: 10.7619/jcmp.201505013
    [5]ZHAO Junwen. Influence of percutaneous coronary intervention on blood flow and inflammatory factors in patients with coronary disease[J]. Journal of Clinical Medicine in Practice, 2015, (5): 1-4. DOI: 10.7619/jcmp.201505001
    [6]LIU Ying, PENG Yansong, MIN Ying, SUN Ning, HAN Yaling. The practice and analysis of nursing mode of percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2014, (20): 1-3,14. DOI: 10.7619/jcmp.201420001
    [7]DING Yongj uan, LYU Juan, GUO Jing, BIAN Yun. Influence of atorvastatin intensive treatment on blood lipid and the level of serum hs-CRP and MMP-9 in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2014, (17): 12-14,21. DOI: 10.7619/jcmp.201417004
    [8]LU Jianjun, YI Liping, TUO Ya, QIAO Huizhen. Expression and clinical significance of matrix metalloproteinases-9 in tissues of endometrial carcinoma[J]. Journal of Clinical Medicine in Practice, 2014, (15): 63-65,69. DOI: 10.7619/jcmp.201415019
    [9]MA Lingling, HOU Chunxia, LING Rong. Nursing of 157 elderly patients with coronary heart disease treated by percutaneous coronary intervention therapy[J]. Journal of Clinical Medicine in Practice, 2014, (10): 1-2,9. DOI: 10.7619/jcmp.201410001
    [10]GAO Mingjun, QI Bo. Influence of irbesartan and amlodipine on carotid-femoral artery pulse wave velocity and serum matrix metalloproteinase-9 level in patients with primary hypertension[J]. Journal of Clinical Medicine in Practice, 2013, (23): 12-14,18. DOI: 10.7619/jcmp.201323004

Catalog

    Article views (146) PDF downloads (0) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return